These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6375843)

  • 21. Calcium antagonists and aneurysmal subarachnoid haemorrhage.
    Lancet; 1983 Jul; 2(8342):141-3. PubMed ID: 6134985
    [No Abstract]   [Full Text] [Related]  

  • 22. Nimodipine does not affect the flow-metabolism couple in permanent cerebral ischemia.
    Gomi S; Burnett MG; Karp A; Greenberg JH
    Exp Brain Res; 2004 Apr; 155(4):469-76. PubMed ID: 14752581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic inhibition of cerebral vasospasm in ischemia, hallucinogen ingestion, and hypomagnesemia: barbiturates, calcium antagonists, and magnesium.
    Altura BM; Altura BT
    Am J Emerg Med; 1983 Sep; 1(2):180-90. PubMed ID: 6680619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage.
    Cook DA
    Pharmacol Ther; 1995 May; 66(2):259-84. PubMed ID: 7667398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of calcium antagonism on the epicerebral circulation in early vasospasm.
    Leblanc R; Feindel W; Yamamoto LY; Milton JG; Frojmovic MM; Hodge CP
    Stroke; 1984; 15(6):1017-20. PubMed ID: 6506112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular effects of calcium antagonists. Uses in some cerebrovascular disorders.
    Marin J
    Gen Pharmacol; 1988; 19(3):295-306. PubMed ID: 2458295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Near-complete resolution of angiographic cerebral vasospasm after extreme elevation of mean arterial pressure: case report.
    Ray WZ; Moran CJ; Derdeyn CP; Diringer MN; Dacey RG; Zipfel GJ
    Surg Neurol; 2009 Oct; 72(4):347-53; discussion 353-4. PubMed ID: 19147203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral vasospasm.
    Mayberg MR
    Neurosurg Clin N Am; 1998 Jul; 9(3):615-27. PubMed ID: 9668192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm].
    Nishizawa Y
    Nihon Rinsho; 1993 Dec; 51 Suppl():389-96. PubMed ID: 8121018
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium channels in cerebral arteries.
    Alborch E; Salom JB; Torregrosa G
    Pharmacol Ther; 1995; 68(1):1-34. PubMed ID: 8604432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cerebral vasospasm following subarachnoid hemorrhage. New aspects of diagnosis and therapy].
    Voth D
    Zentralbl Neurochir; 1987; 48(2):89-101. PubMed ID: 3314267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of tirilazad mesylate on vasospasm and phospholipid hydroperoxides in a primate model of subarachnoid hemorrhage.
    Suzuki H; Kanamaru K; Kuroki M; Sun H; Waga S; Miyazawa T
    Stroke; 1999 Feb; 30(2):450-5; discussion 455-6. PubMed ID: 9933286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis of cerebral vasospasm: with special references to the response of fresh human cerebral arteries to red blood cell hemolysate and the changes in the responses of cerebral arteries to vasoconstrictor substances after subarachnoid hemorrhage].
    Handa Y
    Nihon Geka Hokan; 1987 Mar; 56(2):124-37. PubMed ID: 3115214
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro effects of calcium antagonists PN 200-110, nifedipine, and nimodipine on human and canine cerebral arteries.
    Müller-Schweinitzer E; Neumann P
    J Cereb Blood Flow Metab; 1983 Sep; 3(3):354-61. PubMed ID: 6223932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs.
    Takayasu M; Suzuki Y; Shibuya M; Asano T; Kanamori M; Okada T; Kageyama N; Hidaka H
    J Neurosurg; 1986 Jul; 65(1):80-5. PubMed ID: 3712031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of brain ischemia after aneurysmal subarachnoid hemorrhage.
    Adams HP
    Neurol Clin; 1992 Feb; 10(1):251-68. PubMed ID: 1557006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of lacidipine, a new dihydropyridipine derivative, on various cerebral ischemia models].
    Funato H; Katsuki Y; Yano T; Kawano H; Akada Y; Sato M; Uemura A
    Nihon Yakurigaku Zasshi; 1996 Nov; 108(5):243-57. PubMed ID: 8974085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of intracranial vasospasm in rupture of cerebral aneurysm].
    Ryba M; Iwańska K; Pastuszko M
    Neurol Neurochir Pol; 1991; 25(6):788-95. PubMed ID: 1811186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of gamma 2-melanocyte-stimulating hormone and nimodipine on cortical blood flow and infarction volume in two rat models of middle cerebral artery occlusion.
    Herz RC; De Wildt DJ; Versteeg DH
    Eur J Pharmacol; 1996 Jun; 306(1-3):113-21. PubMed ID: 8813623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.